Cyclarity Therapeutics Overview
- Year Founded
-
2019
- Status
-
Private
- Employees
-
11
- Latest Deal Type
-
Later Stage VC
- Latest Deal Amount
-
$6M
- Investors
-
13
Cyclarity Therapeutics General Information
Description
Developer of compound-based drugs designed to treat the underlying causes of age-related diseases. The company's drugs offer simple and direct interventions targeting toxic forms of cholesterol, using rationally designed molecules to remove arterial plaque by clearing the non-degradable cholesterol, enabling clinicians to provide patients with disease-modifying treatments for age-related diseases such as atherosclerosis, hypercholesterolemia, heart failure, and macular degeneration.
Contact Information
Website
www.cyclaritytx.comCorporate Office
- 8001 Redwood Boulevard
- Novato, CA 94945
- United States
Corporate Office
- 8001 Redwood Boulevard
- Novato, CA 94945
- United States
Cyclarity Therapeutics Timeline
Cyclarity Therapeutics Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 6. Later Stage VC | 25-Mar-2026 | $6M | Completed | Clinical Trials - Phase 1 | ||
| 5. Later Stage VC | 17-Dec-2024 | Completed | Pre-Clinical Trials | |||
| 4. Seed Round | 23-Sep-2021 | Completed | Pre-Clinical Trials | |||
| 3. Grant | 05-Sep-2021 | Completed | Pre-Clinical Trials | |||
| 2. Seed Round | 14-Nov-2019 | $3.95M | $7.73M | Completed | Pre-Clinical Trials | |
| 1. Accelerator/Incubator | $3.78M | $3.78M | Completed | Pre-Clinical Trials |
Cyclarity Therapeutics Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series A-3 | ||||||||
| Series A-2 | ||||||||
| Series A-1 | ||||||||
| Seed II | 9,654,367 | $0.000010 | 8% | $1.04 | $1.04 | 1x | $0.91 | 24.35% |
| Seed | 4,536,844 | $0.000010 | 8% | $0.87 | $0.87 | 1x | $0.81 | 10.79% |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Cyclarity Therapeutics Comparisons
Industry
Financing
Details
Cyclarity Therapeutics Competitors (4)
One of Cyclarity Therapeutics’s 4 competitors is Cardurion, a Venture Capital-Backed company based in Burlington, MA.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Cardurion | Venture Capital-Backed | Burlington, MA | ||||
| XyloCor Therapeutics | Venture Capital-Backed | King of Prussia, PA | ||||
| Renova Therapeutics | Venture Capital-Backed | Carlsbad, CA | ||||
| Dicerna Pharmaceuticals | Formerly VC-backed | Lexington, MA |
Cyclarity Therapeutics Patents
Cyclarity Therapeutics Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| JP-2023533745-A | Cyclodextrin dimer and use thereof | Active | 07-Jul-2020 | ||
| JP-2026120622-A | Cyclodextrin dimers and their use | Pending | 07-Jul-2020 | ||
| JP-7851622-B2 | Cyclodextrin dimers and their use | Active | 07-Jul-2020 | ||
| AU-2021306298-A1 | Cyclodextrin dimers and uses thereof | Pending | 07-Jul-2020 | ||
| CA-3184962-A1 | Cyclodextrin dimers and uses thereof | Pending | 07-Jul-2020 | C08B37/0012 |
Cyclarity Therapeutics Signals
Cyclarity Therapeutics Investors (13)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Cistern Capital | Venture Capital | Minority | ||
| Immortal Dragons | Venture Capital | Minority | ||
| Ki Tua Fund | Corporate Venture Capital | Minority | ||
| Seed Healthcare | Venture Capital | Minority | ||
| Starbloom Capital | Venture Capital | Minority |
Cyclarity Therapeutics FAQs
-
When was Cyclarity Therapeutics founded?
Cyclarity Therapeutics was founded in 2019.
-
Where is Cyclarity Therapeutics headquartered?
Cyclarity Therapeutics is headquartered in Novato, CA.
-
What is the size of Cyclarity Therapeutics?
Cyclarity Therapeutics has 11 total employees.
-
What industry is Cyclarity Therapeutics in?
Cyclarity Therapeutics’s primary industry is Drug Discovery.
-
Is Cyclarity Therapeutics a private or public company?
Cyclarity Therapeutics is a Private company.
-
What is Cyclarity Therapeutics’s current revenue?
The current revenue for Cyclarity Therapeutics is .
-
How much funding has Cyclarity Therapeutics raised over time?
Cyclarity Therapeutics has raised $34M.
-
Who are Cyclarity Therapeutics’s investors?
Cistern Capital, Immortal Dragons, Ki Tua Fund, Seed Healthcare, and Starbloom Capital are 5 of 13 investors who have invested in Cyclarity Therapeutics.
-
Who are Cyclarity Therapeutics’s competitors?
Cardurion, XyloCor Therapeutics, Renova Therapeutics, and Dicerna Pharmaceuticals are competitors of Cyclarity Therapeutics.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process